CHO Pharma, Inc. (6586.TWO)

TWD 53.5

(0.38%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue - 60 Thousand 3.57 Million 138 Thousand 297 Thousand
Cost of Revenue 28.27 Million 1000.00 211 Thousand 71 Thousand 119 Thousand
Gross Profit -28.27 Million 59 Thousand 3.35 Million 67 Thousand 178 Thousand
Operating Expenses 268.99 Million 350.95 Million 213.85 Million 309.62 Million 370.2 Million
Selling, General and Administrative Expenses 29.61 Million 24.86 Million 20.34 Million 21.74 Million 24.71 Million
Research and Development Expenses 239.38 Million 326.09 Million 193.5 Million 287.88 Million 344.63 Million
Other Expenses - 5.75 Million -319 Thousand 5.38 Million -
Cost and Expenses 268.99 Million 350.96 Million 214.06 Million 309.69 Million 370.32 Million
Operating Income -268.99 Million -338.09 Million -205.34 Million -296.06 Million -369.16 Million
Interest Expense 77 Thousand 301 Thousand 576 Thousand 775 Thousand 401 Thousand
Income Tax Expense - - - - -
Earnings before Tax -306.08 Million -338.39 Million -205.92 Million -296.83 Million -358.37 Million
Net Income -306.08 Million -338.39 Million -205.92 Million -296.83 Million -358.37 Million
Earnings Per Share Basic -1.60 -1.84 -1.12 -1.62 -1.96
Earnings Per Share Diluted -1.60 -1.84 -1.12 -1.62 -1.96
Weighted Average Shares Outstanding 191.32 Million 183.96 Million 183.88 Million 183.67 Million 183.01 Million
Weighted Average Shares Outstanding (Diluted) 191.32 Million 183.96 Million 183.88 Million 183.67 Million 183.01 Million
Gross Margin - 0.98 0.94 0.49 0.60
EBIT Margin - -4970.70 -46.57 -1846.54 -1144.59
Profit Margin - -5639.88 -57.68 -2151.01 -1206.64
EBITDA -277.73 Million -302.27 Million -170.15 Million -258.92 Million -323.91 Million
Earnings Before Tax Margin - -5634.87 -57.52 -2145.39 -1242.97

Income Statement Charts